Aurora Cannabis Q2 revenues surge as it captures 20 per cent of Canadian sales Cannabis, Life Science
Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China Life Science
Vitruvias Therapeutics Inc. Enters into a Semi-Solid (Topical) Licensing Agreement with Hong Kong-Based Bright Future Life Science
CStone and IMPACT Therapeutics’ clinical collaboration progresses to IND filing acceptance for CS1001+IMP4297 combination therapy Life Science
HiberCell Launches With $60.75 Million Series A to Target Dormant Metastatic Cancer Cells Life Science